Many people diagnosed with non-Hodgkin's lymphoma take part in clinical trials (research studies). Doctors conduct clinical trials for non-Hodgkin’s lymphoma to learn about the effectiveness and side effects of new non-Hodgkin's lymphoma treatments. In some trials, all patients receive the new treatment. In others, doctors compare different therapies by giving the new treatment to one group of patients and the standard non-Hodgkin's lymphoma therapy to another group; or they may compare one standard treatment with another. Research like this has led to significant advances in the treatment of cancer. Each achievement brings researchers closer to the eventual control of cancer.
Doctors are studying radiation therapy, new ways of giving chemotherapy, new anticancer drugs and drug combinations, biological therapies, bone marrow transplantation, peripheral blood stem cell transplantation, and new ways of combining various types of treatment. Some studies are designed to find ways to reduce the side effects of non-Hodgkin's lymphoma treatment and to improve the patient's quality of life.
People who take part in these studies have the first chance to benefit from treatments that have shown promise in earlier non-Hodgkin’s lymphoma research. They also make an important contribution to medical science and the advancement of non-Hodgkin's lymphoma research. Patients who are interested in taking part in a clinical trial should talk with their doctor.